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Abstract
Background: The public health response to pandemic influenza is contingent on the pandemic strain’s severity. In late April
2009, a potentially pandemic novel H1N1 influenza strain (nH1N1) was recognized. New York City (NYC) experienced an
intensive initial outbreak that peaked in late May, providing the need and opportunity to rapidly quantify the severity of
nH1N1.
Methods and Findings: Telephone surveys using rapid polling methods of approximately 1,000 households each were
conducted May 20–27 and June 15–19, 2009. Respondents were asked about the occurrence of influenza-like illness (ILI,
fever with either cough or sore throat) for each household member from May 1–27 (survey 1) or the preceding 30 days
(survey 2). For the overlap period, prevalence data were combined by weighting the survey-specific contribution based on a
Serfling model using data from the NYC syndromic surveillance system. Total and age-specific prevalence of ILI attributed to
nH1N1 were estimated using two approaches to adjust for background ILI: discounting by ILI prevalence in less affected
NYC boroughs and by ILI measured in syndromic surveillance data from 2004–2008. Deaths, hospitalizations and intensive
care unit (ICU) admissions were determined from enhanced surveillance including nH1N1-specific testing. Combined ILI
prevalence for the 50-day period was 15.8% (95% CI:13.2%–19.0%). The two methods of adjustment yielded point estimates
of nH1N1-associated ILI of 7.8% and 12.2%. Overall case-fatality (CFR) estimates ranged from 0.054–0.086 per 1000 persons
with nH1N1-associated ILI and were highest for persons$65 years (0.094–0.147 per 1000) and lowest for those 0–17 (0.008–
0.012). Hospitalization rates ranged from 0.84–1.34 and ICU admission rates from 0.21–0.34 per 1000, with little variation in
either by age-group.
Conclusions: ILI prevalence can be quickly estimated using rapid telephone surveys, using syndromic surveillance data to
determine expected ‘‘background’’ ILI proportion. Risk of severe illness due to nH1N1 was similar to seasonal influenza,
enabling NYC to emphasize preventing severe morbidity rather than employing aggressive community mitigation
measures.
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Introduction
The public health response to an emerging influenza
pandemic, particularly whether to initiate aggressive community
mitigation strategies such as school closure, depends in part on
the severity of illness caused by the potentially pandemic strain:
whether it has a more severe disease rate or higher mortality than
usually seen with seasonal influenza [1]. Determining severity of
illness as soon as possible after a potentially pandemic influenza
strain is recognized is thus one of the highest priorities for public
health authorities.
In the United States, a key measure for categorizing the
potential severity of a pandemic strain is the case-fatality rate
(CFR) among those infected [1]. The major challenge to directly
calculating the CFR rate is specifying the denominator of how
many people have been infected, given that most disease does not
require hospital care, many persons do not and are advised not to
seek medical attention, and strain-specific diagnostic testing
capacity is likely to be limited.
Population-based telephone surveys can be a useful way to
quickly assess and monitor the prevalence and distribution of
influenza-like illness (ILI) in the community. However, they do not
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distinguish between influenza and other causes of ILI (e.g.,
respiratory syncytial virus, rhinoviruses, coronaviruses, parainflu-
enza viruses) and their use to rapidly estimate the prevalence of
influenza is challenging.
On April 24, 2009, New York City (NYC) became the third
geographic area of the US in one week to document the presence
of novel H1N1 (nH1N1), later declared pandemic influenza
(H1N1) 2009 [2,3]. The first confirmed NYC cases occurred in
students attending a high school in Queens, where approximately
a third of the 2,700 students developed ILI during the course of a
week [4]. In response, the NYC Department of Health and Mental
Hygiene (DOHMH) implemented a multifaceted surveillance
approach to understand the severity of illness, and the scope,
distribution, and impact of nH1N1 in NYC [3,5]. In addition to
establishing surveillance for more severe illness including deaths
and hospitalizations due to nH1N1, we used rapid, population-
based telephone surveys to estimate the total burden of ILI and
nH1N1 in NYC and, thus, enable rapid estimation of case-fatality
and hospitalization rates.
This paper presents our estimates of the prevalence of nH1N1
during the 50 days of peak circulation of nH1N1 in NYC, the
methods used to derive them, and the resulting case-fatality,
hospitalization and intensive care unit (ICU) admission rates. To
our knowledge, NYC was the only area of the country to directly
obtain population-level ILI or nH1N1 prevalence during the
initial spring 2009 wave of the pandemic.
Methods
Methods used included serial population surveys to estimate ILI
prevalence for the time period May 1–June 19, 2009, use of two
separate methods to determine and then discount estimates for
background ILI in order to estimate nH1N1 prevalence, and
calculation of case-fatality, intensive care unit (ICU) admission and
hospitalization rates using data from surveillance for deaths, ICU
admissions and hospitalizations during this time period for
numerators.
Ethics
The investigation of this novel strain of influenza in April/May,
2009, including the population-based telephone surveys, was
deemed public health practice and not human subjects research by
both the General Counsel and the Institutional Review Board
Chair of the New York City Department of Health and Mental
Hygiene, and therefore did not require Institutional Review Board
review.
Population Surveys
DOHMH employed rapid telephone polling methods typically
used in public opinion research to assess ILI prevalence among
both adults and children during two overlapping periods in May
and June 2009. We conducted two polls of approximately 1,000
households each, between May 20 and May 27, and between June
15 and June 19, 2009. This size sample was adequate to generate a
reliable citywide prevalence estimate yet still be conducted quickly.
Household samples of 1000 would typically yield data on more
than 2500 persons. The predicted 95% margin of error around an
estimated prevalence of 50% in such a sample is less than +/2
2%, even after adjusting for non-response weighting. We used a
random-digit dialing telephone sampling methodology to obtain
data from a random sample of residential households in NYC. A
nonrandom adult from each household was asked to provide
information on all household members. Interviews lasted 5 min-
utes and were conducted in both English and Spanish. Sampled
numbers were dialed between five and six times to contact and
interview a household, or until the sampled number was
determined to be non-working. For the first survey, the Council
of American Survey Research Organizations (CASRO) response
rate 3 (RR3) was 8.4% with a cooperation rate of 31.2% [6]. For
the second survey, the RR3 was 8.4% with a cooperation rate of
27.9%.
For each survey, the analysis dataset contained a record for
every enumerated household member. Household members were
linked by a household ID. Data were weighted to population
estimates from the 2007 American Community Survey (ACS) [7].
Respondents were weighted to the 2007 ACS head of household
distribution by borough (NYC has five boroughs), age group (0–17
years, 18–64 years, 65+ years), gender, number of persons in the
household and race/ethnicity. Other household members were
weighted to the non-head of household population by borough,
age-group, household composition, and respondent’s race/ethnic-
ity to generate population estimates of ILI by age group.
ILI was defined as having fever and either cough or sore throat
during the specified time period. In the first survey, respondents
were asked whether they or other household members had
experienced fever and either cough or sore throat between May
first and the date of the interview (May 20–27). Information on
household members was recorded by age group. In the second
survey, the same procedures were used, but the time frame was
changed to the past 30 days (May 15–19 to June 15–19).
The surveys included two overlapping time periods with
different estimates of ILI prevalence. To combine the surveys,
an estimate was needed of the proportion of ILI cases reported in
each survey that occurred in the 13 day overlapping time period,
May 15–27. Ideally, this should reflect the underlying epidemic
curve for ILI in NYC during this time. To approximate this, we
used emergency department (ED) visit data from our syndromic
surveillance system. This system includes daily information on
92% of all hospital ED visits in NYC. Chief complaints are used to
classify visits into syndrome categories, including an ILI category
that utilizes a definition similar to the survey question, but which
can also include the word ‘‘flu’’ [8,9].
For each survey, the number of ED ILI visits occurring during
the non-overlap and overlap periods was calculated by age, sex,
and borough. Assuming that the ILI prevalence reported in the
survey followed the same distribution as the ED visits (Figure 1),
the proportion of ILI from each survey that was in the overlap
period could be estimated. The prevalence for the overlap period
was then determined to be the value in the interval between two
survey-specific estimates that best fit the ratios (overlap to non-
overlap) implied by the ED ILI visits. The ILI prevalence estimates
during each non-overlap survey period plus the overlap period
were then combined.
Adjustment for background ILI
Two approaches were used to estimate background ILI activity
expected in the absence of nH1N1. Each approach produced
overall and age group-specific estimates of background ILI
activity. Each estimate of background ILI activity was applied to
the combined survey data point prevalence to produce estimates of
the percentage of NYC residents affected by nH1N1 from May 1
through June 19, 2009. Ninety-five percent confidence limits,
adjusted for the complex survey design, were calculated around
the adjusted point estimates.
Method 1: Using geographic differences in nH1N1 activity
to estimate background ILI. During the reporting period of
the May survey, results from ongoing enhanced surveillance of
laboratory-confirmed hospitalized nH1N1 cases and of emergency
nH1N1 Case Fatality Rates, NYC
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department visits for ILI suggested that community transmission of
nH1N1 was occurring primarily in certain parts of the city. Most
cases were coming from the area in Queens surrounding the
location of the initial high school outbreak, and from selected parts
of Brooklyn. Assuming no geographic variability in the ratios of
nH1N1 hospitalizations to nH1N1 prevalence and of nH1N1
prevalence to ILI prevalence, we hypothesized that ILI prevalence
in the less affected areas would be largely attributable to causes
other than nH1N1. Following this logic, we defined background
ILI prevalence as the average prevalence from the initially less
affected boroughs, Bronx, Manhattan and Staten Island from the
first survey, overall and by age group, and assumed the same
background rate for the entire survey period. The rates for the first
survey period were calculated based on the distribution by date of
responses to the May 20–27 survey, averaging approximately 23.1
days from May 1 and, thus, giving a 23.1 day prevalence. This
estimate was then expanded to the full 50 day period. We then
subtracted our estimates of background ILI from the combined
ILI prevalence estimates to produce estimates of nH1N1
prevalence for the period May 1–June 19, 2009.
Method 2: Using auxiliary data from previous years to
estimate background ILI. The second method used data from
the ED syndromic surveillance system to adjust for background
ILI. Using data from EDs reporting consistently over the
preceding 5 years, we constructed an age group-specific Serfling
model, similar to what is used for estimating excess mortality due
to influenza. [10]. The Serfling models estimated the expected
number of ILI visits in the absence of any type of influenza and
were fit separately by age group and included seasonal terms,
linear and quadratic trends, and day of week effects to adjust for
differential health seeking behavior. This provided a baseline
estimate of daily ILI visits in the absence of influenza for the
period May 1st to June 19th. Daily ED ILI visit data from 2009
were then used to reflect combined background ILI and nH1N1
activity and excess visits due to nH1N1 were calculated by
subtracting the expected visits from observed values. The daily
proportion of ED visits for ILI attributable to nH1N1 were then
combined and applied to the ILI estimates for the three survey
periods, the two non-overlapping periods and the overlap period,
to estimate the prevalence of ILI due to nH1N1.
Deaths, hospitalization and ICU admission surveillance
During this time period, active surveillance for the first 3 weeks
followed by enhanced surveillance was conducted for deaths
through all NYC hospitals and the medical examiner’s office,
including nH1N1 specific testing. For most of the period,
enhanced surveillance for hospitalizations and ICU admissions
due to nH1N1 was also conducted, including nH1N1 specific
testing on persons hospitalized who tested influenza A positive and
on all persons admitted to the ICU with acute respiratory illness,
including ILI. Details of the surveillance efforts are described
elsewhere [11,12]. Eligible cases were persons who died or were
hospitalized with laboratory-confirmed or probable (confirmed
influenza A, not subtyped) nH1N1 infection with either onset of
symptoms between May 1–June 19, 2009 inclusive or, in the
absence of an onset date, first came to medical attention during
this time period.
Calculation of case-fatality, hospitalization and ICU
admission rates
Two sets of case-fatality, hospitalization and ICU admission
rates were calculated using numerators obtained through popu-
lation-based nH1N1 death and hospitalization surveillance and
each of the two sets of denominators of persons estimated to have
had ILI due to nH1N1 from the population surveys after
adjustment for background ILI. Overall and age group-specific
rates were generated.
Figure 1. Overall and age-specific daily rates of ED visits for ILI, NYC, May–June 2009. Rate is number of emergency department (ED) visits
for influenza-like illness (ILI) per 100,000 age-group specific population. Survey 1 was conducted from May 21–27 and measured ILI from May 1–27.
Survey 2 was conducted June 15–19 and measured ILI from May 15 to June 19. The overlap period is from May 15–May 27.
doi:10.1371/journal.pone.0011677.g001
nH1N1 Case Fatality Rates, NYC
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Statistical Methods
ILI prevalence estimates and confidence intervals were
produced using SAS-callable SUDAAN Statistical Methods
software to adjust standard errors for complex survey design.
Compound estimates such as the combined survey estimate of
nH1N1 prevalence attributable ILI were generated using Monte
Carlo methods with the R statistical package.
Results
ILI prevalence estimates
Table 1 presents the ILI prevalence estimates from each survey,
as well as the combined estimates overall, by age-group and by
borough.
Total ILI prevalence during the May 1–May 27 period was
6.9%. Prevalence was considerably higher in children (11.7%)
than in adults (5.7%) or older adults (4.3%). There was geographic
variability in ILI prevalence during this period. Prevalence was
high in Brooklyn (9.0%) and Queens (9.4%) and lower in the three
boroughs chosen to represent background ILI, Bronx (3.6%),
Manhattan (3.7%) and Staten Island (4.2%).
Total ILI prevalence for the period May 15, 2009–June 19,
2009 was 12.0%, with age-related differences ranging from 21.1%
in children 0–17 years to 5.7% in those 65 years and older. No
variability in ILI prevalence by borough was observed during this
time period.
After combining data from the two surveys, the estimated
overall ILI prevalence was 15.8% (estimated N=1,318,000 NYC
residents), with age-specific estimates ranging from 26.6% among
children ages 0–17 years, to 13.2% among adults 18–64 years and
8.8% among adults $65 years.
Estimates of nH1N1 prevalence from combined ILI data
The results of each approach after adjusting for background ILI
to obtain estimates of nH1N1 prevalence are presented in Table 2.
The two methods gave nH1N1 point-prevalence estimates that
were approximately 1.6-fold different. Method 1 resulted in an
overall nH1N1 prevalence of 7.8%, with age-specific prevalence of
13.1% for children ,18 years, 6.6% for adults 18–64 years, and
3.2% for those $65 years. By contrast, method 2 resulted in
nH1N1 prevalence of 12.2% overall and 20.0%, 10.8%, and 5.1%
in children, adults, and older adults, respectively.
Case-fatality, hospitalization and ICU admission rates
Table 3 shows the overall and age-specific CFR, hospitalization
and ICU admission rates for ILI due to nH1N1 by the two
methods of adjustment for background ILI. The overall CFR
ranged from 0.054 to 0.086 per 1,000 persons with ILI due to
nH1N1. There was a strong association with age (p = 0.00001, chi-
square for trend), with the CFR being more than 11-fold higher
for those $65 years compared to children 0–17 years by each
adjustment method. The CFR for those$65 ranged from 0.094 to
0.147 per 1,000 persons.
The overall hospitalization rate ranged from 0.84 to 1.34 per
1,000 persons with ILI due to nH1N1. Children 0–17 years were
at slightly higher risk for hospitalization than those who were older
(RR=1.22, 95% CI 1.06–1.39, p,0.01, adjustment method 1;
RR=1.30, 95% CI 1.13–1.48, p,0.001, adjustment method 2).
The overall ICU admission rate ranged from 0.21 to 0.34 per
1,000 persons with ILI due to nH1N1. There was no variation in
ICU admission rates by age. However, the percentage of
hospitalized cases who were admitted to the ICU did vary slightly
by age. Adults 18 years and older were more likely than children
0–17 years to be admitted to the ICU (27.6% vs 21.5%,
RR=1.28, 95% CI 1.01–1.63).
Discussion
It is critical to assess the severity of a potentially pandemic strain
of influenza as soon as possible after it is recognized in order to
Table 1. Overall and survey-specific ILI prevalence estimates by sex, age-group and borough, New York City, May 1–June 19, 2009.
Survey 1* Survey 2* Combined Estimate May 1–June 19
Number with
ILI**
Percent with
ILI 95% CI
Number with
ILI**
Percent with
ILI 95% CI
Number with
ILI**
Percent with
ILI 95% CI
Total 576,000 6.9 6.0–7.9 1,007,000 12.0 10.0–14.6 1,318,000 15.8 13.2–19.0
Sex
Male 266,00 6.7 5.3–8.5 402,000 10.1 7.5–13.3 540,000 13.5 10.2–18.0
Female 314,00 7.2 6.0–8.7 608,000 13.9 10.7–17.6 764,000 17.5 13.6–22.1
Age Group
0–17 224,000 11.7 9.2–14.7 405,000 21.1 15.9–26.7 510,000 26.6 20.1–34.0
18–64 306,000 5.7 4.6–6.8 544,000 10.1 7.6–13.3 717,000 13.2 10.2–17.2
65+ 45,000 4.3 3.0–6.3 59,000 5.7 4.1–7.1 91,000 8.8 6.2–12.6
Borough
Bronx 50,000 3.6 2.2–5.7 127,000 9.1 5.8–13.4 155,000 11.1 7.0–16.6
Brooklyn 230,000 9.0 7.2–11.4 335,000 13.1 10.1–17.1 452,000 17.7 13.7–23.4
Manhattan 61,000 3.7 2.3–5.8 184,000 11.3 7.8–15.5 217,000 13.3 9.1–18.6
Queens 217,000 9.4 7.0–12.7 280,000 12.2 8.2–18.6 383,000 16.7 11.6–25.4
Staten Island 20,000 4.2 2.3–7.4 87,000 17.9 7.3–34.8 98,000 20.1 8.6–38.9
*Survey 1 conducted May 21–27, covering time period May 1–27. Survey 2 conducted June 15–19, covering time period May 15–June 19.
**Number with influenza-like illness (ILI) calculated by multiplying the group-specific 2007 population estimates by the percent with ILI and rounding to the nearest
1000.
doi:10.1371/journal.pone.0011677.t001
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inform the public and to guide public health response. Defining
the risk of death following infection with a pandemic strain enables
categorization of the potential severity of the pandemic, with a
CFR of ,1 death per 1000 persons infected being the criteria for
the lowest severity, Category 1 pandemic strain [1]. Defining the
risk of hospitalization enables projecting and planning for the
burden on hospitals. To define these risks, it is essential to have
both enough infections and a way to measure them, given that
most influenza strains have a case-fatality rate of less than one per
thousand symptomatic infections. In the first wave of pandemic
influenza A H1N1 2009, New York City was in a position to
attempt determination of CFR, given that it was particularly hard
hit early. Using rapid polling techniques to obtain estimates of ILI,
we had rough estimates of the number of nH1N1 infections within
a week of completion of the first survey. At this time, surveillance
for hospitalizations, observation of school outbreaks and the survey
data collectively suggested that the outbreak was widespread,
school-aged children were most affected, and the CFR appeared
to be low. Thus, NYC adjusted response policies to focus on
prevention and treatment of severe disease instead of community
Table 2. nH1N1 prevalence estimates by adjustment method and age-group, New York City, May 1 to June 19, 2009.
Combined
Data May 1–
June 19 Adjustment Method 1* Adjustment Method 2**
Estimated ILI
Percent
Prevalence
(95% CI)
Estimated
Percent
Background ILI
(95% CI)
Estimated
Percent nH1N1
Prevalence
(95% CI)
Estimated
Number with
nH1N1 (95% CI)
Estimated
Percent
Background
ILI (95% CI)
Estimated
Percent nH1N1
Prevalence
(95% CI)
Estimated Number
with nH1N1 (95% CI)
NYC 15.8 (13.2–19.0) 8.0 (5.9–10.9) 7.8 (4.4–10.5) 639,000 (367,000–
880,000)
3.6 (3.1–4.3) 12.2 (10.1–14.6) 1,017,000 (848,000–
1,231,000)
Age-Group
0–17 years 26.6 (20.1–34.0) 13.5 (8.4–21.5) 13.1 (4.5–20.2) 250,000 (87,000–
388,000)
6.6 (5.0–8.5) 20.0 (15.1–25.5) 383,000 (290,000–488,000)
18–64 years 13.2 (10.2–17.2) 6.6 (4.4–9.9) 6.6 (2.6–9.4) 355,000 (156,000–
548,000)
2.5 (2.0–3.2) 10.8 (8.3–14.0) 582,000 (446,000–758,000)
65+ years 8.8 (6.2–12.6) 5.6 (3.0–9.8) 3.2 (0.0–6.5) 34,000 (0–68,000) 3.7 (2.6–5.4) 5.1 (3.6–7.2) 53,000 (37,000–75,000)
*Adjustment Method 1 uses survey 1 data from the less affected boroughs to estimate background ILI.
**Adjustment Method 2 uses emergency department visit data for ILI from 2004–2008 to estimate background ILI.
doi:10.1371/journal.pone.0011677.t002
Table 3. Estimated case-fatality and case-hospitalization rates among persons with ILI due to nH1N1, by adjustment method, New
York City, May 1–June19, 2009.
Adjustment Method 1 Adjustment Method 2
No. Cases No. persons nH1N1*
Rate/1000 persons
nH1N1** No. persons nH1N1*
Rate/1000 persons
nH1N1**
Fatalities
All 55 639,000 0.086 1,017,000 0.054
0–17 years 3 250,000 0.012 383,000 0.008
18–64 years 47 355,000 0.132 582,000 0.081
65+ years 5 34,000 0.147 53,000 0.094
Hospitalizations
All 859 639,000 1.34 1,017,000 0.84
0–17 years 377 250,000 1.51 383,000 0.98
18–64 years 440 355,000 1.24 582,000 0.76
65+ years 42 34,000 1.24 53,000 0.79
ICU admissions
All 214 639,000 0.335 1,017,000 0.210
0–17 years 81 250,000 0.324 383,000 0.211
18–64 years 122 355,000 0.344 582,000 0.210
65+ years 11 34,000 0.323 53,000 0.208
*Point estimate of number of persons with nH1N1 from Table 2.
**[No. cases]/[No. persons with nH1N1]61,000.
doi:10.1371/journal.pone.0011677.t003
nH1N1 Case Fatality Rates, NYC
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mitigation, including minimizing the number of school closings.
Further, results of the first survey were released to the public to
rapidly generate a more complete profile of illness burden and
severity. After the second survey was completed, we shared survey
findings without adjustment for background ILI with other
researchers who were piecing together severity profiles from
multiple cities to generate the multiplier model severity estimates
that were initially published in September 2009 and which
included preliminary NYC survey data (5). However, we needed
sufficient time to measure deaths and hospitalizations and
agreement on methods to combine the two surveys and adjust
for background ILI before having confidence in the resulting
specific estimates of case-fatality and hospitalization rates. Findings
described here confirmed that the case-fatality rate was indeed low
and well below 1 per thousand symptomatic infections for each
age group, further supporting the policies adopted based on
observations of school children.
Measuring influenza CFRs in ‘‘real-time’’ to inform public
health efforts is a challenge that was acknowledged at the
beginning of this pandemic [13,14]. One method proposed in
national pandemic planning materials was determination of the
attack rate and CFR in a number of closed outbreaks and
combining them [1]. However, this method was not used in this
rapidly evolving pandemic. Instead, two different methods were
used in the US. One used a multiplier model in which data from a
number of sources were used to determine the ratio of medically
attended visits to persons with ILI, the percentage of medical visits
that were confirmed as due to pandemic influenza, the percentage
of confirmed pandemic influenza infections that were hospitalized
and the ratio of deaths to hospitalizations, with CFR and
hospitalization rates then calculated using the respective multipli-
ers [5,15]. The other is the method described in detail in this paper
but also applied to the crude initial ILI survey data from NYC in
another paper [5], based on a direct estimation of the number of
persons affected by pandemic influenza and the number of persons
who died and/or were hospitalized who were confirmed to have
pandemic influenza infection.
These methods have produced widely different measures of
CFR, hospitalization and ICU admission rates due to pandemic
H1N1 influenza in the US. The CFR ranges from a potentially
low estimate of 0.05–0.09 per thousand based on our population
survey data and 55 deaths, to a potentially high estimate of 0.48 to
5.1 per 1000 based on use of multipliers tied to 788 medically
attended confirmed infections, 25 hospitalizations and 4 deaths in
Milwaukee [5]. Age group-specific CFRs, hospitalization and ICU
admission rates using these two methods also had approximately
10-fold higher estimates using the multiplier method.
Why were there such large differences between the two ways of
estimating severity, especially since they have different implica-
tions for hospital preparedness? Is one method potentially more
accurate than the other? We believe that the method used in NYC
is more likely to produce an accurate measure of CFR simply
because it is only dependent on two measures: population-level
infection and deaths. The multiplier method is dependent on more
measures and includes projection from the number of people
diagnosed to the number seen for ILI and from the number seen
to the number who were symptomatic. In this case, two additional
factors could play a role: the numbers of confirmed cases and
hospitalizations used in the multiplier model were small (788 and
25) and the data used to project from confirmed cases to estimate
the population affected were obtained from studies done elsewhere
and in special settings during the H1N1 pandemic (Chicago and
Delaware) or from community surveys done when seasonal
influenza was circulating [15].
We believe the NYC data, while still reflecting a range of
estimates, to be fairly accurate for at least three reasons. First,
numerator data were based on enhanced death surveillance
including deaths referred to the medical examiner with specific
testing for nH1N1 of all suspect deaths. Outpatient deaths were
able to be identified and included. Second, despite low response
rates on the survey, our ILI and nH1N1 prevalence data are
consistent with data from other sources. The first survey showed a
strong age-specific gradient with much higher prevalence in areas
of NYC with initial amplification of nH1N1 and the data from the
second survey were more uniform and much higher. These
findings were consistent with hospitalization and ED syndromic
surveillance data. In addition, the methods for adjustment for ILI
likely produced artificially low and high estimates of nH1N1
prevalence, estimates that encompassed the actual prevalence.
Assuming the baseline ILI prevalence in the absence of nH1N1
was the measured ILI in the first survey in boroughs with minimal
nH1N1 activity based on hospitalization and ED syndromic
surveillance data, we likely overestimated the background ILI rate
and, correspondingly, had low nH1N1 prevalence estimates.
Halfway through the first survey time period, it was clear from ED
data that visits for ILI were increasing in those boroughs, a sign of
nH1N1 activity spreading to them. Thus, the background ILI rates
likely included nH1N1-related ILI. On the other hand, the ED
syndromic surveillance adjustment method likely overestimated
total ILI rates and, correspondingly, overestimated nH1N1 rates.
In NYC, as in many other places in the US, people with ILI
appeared to be more likely to go to the ED than normally would
have in hopes of getting tested for nH1N1. Third, NYC clearly
had a high nH1N1 prevalence during the first pandemic wave, one
of the highest in the country based on death reports (25% of US
reported nH1N1 deaths as of July 2, 2009) [16] and magnitude of
ILI ED visits (peak of 16.5% of all ED visits on May 24 and 25
(unpublished data, NYC Department of Health and Mental
Hygiene). The prevalence of nH1N1 infection was high enough to
prevent a substantial second wave in the fall, during which activity
in NYC was lower than in almost all other parts of the country (by
week, peak of 4.4% of ED visits for ILI) [17]. If one projects from
the NYC deaths occurring from May 1–June 19, 2009 using the
median symptomatic CFR from the multiplier estimates (0.048%
CFR) [5], then only 1.4% of NYC residents would have had ILI
due to nH1N1 during our study period, a percentage which if
doubled to 2.8% to account for asymptomatic infection would still
be unlikely to produce much in the way of herd immunity. The
estimates from the population survey which result in 7.8% to
12.2% of NYC residents having had symptomatic nH1N1
infection, especially if doubled to account for asymptomatic
infection, are in a range that could explain the relatively low level
of second wave activity.
Except for those 65 years and older, our estimates of age group-
specific CFR for nH1N1 are almost identical to those derived from
mortality data for seasonal influenza from 1990–1999, the data
that forms the basis for the widely cited statistic that seasonal
influenza causes an estimated 36,000 deaths per year in the US
[18]. Assuming between 5% to 20% of the population is infected
with seasonal influenza viruses each year, the annual CRFs per
1000 influenza infections from 1990–1999 are .01–.04 for 0–17
year olds, .03–.11 for 18–64 year olds, and 1.1–4.4 for those 65
and older. The range of age group-specific CFRs from nH1N1 in
our study were .008–.012, .08–.13 and .09–.15, respectively. Given
that nH1N1 attack rates were highest in younger persons who had
the lowest CFR and that the number of deaths and CFR in the
elderly were relatively low compared to seasonal influenza, the
overall mortality from nH1N1 could be expected to be lower than
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that found in most influenza seasons. Our overall nH1N1 CFR
ranged from .05–.09 per 1000 cases of ILI compared to a CFR for
seasonal influenza ranging from 0.16–0.62 per 1000 influenza
infections from 1990–1999, ranges encompassing 2.9 to nearly 7-
fold differences. Given this mortality data, overall infection rates
with nH1N1 would have to be 2.6–7-fold higher than with
seasonal influenza to achieve average seasonal influenza mortality.
The lack of increased severity of illness of a pandemic strain was
not fully anticipated in most pandemic influenza planning
scenarios, although it was accounted for in the influenza severity
index developed by CDC in its Community Mitigation Strategy
[1].
During the spring wave of nH1N1, it was noted in several
journal articles that it is very difficult to measure case-fatality rates
early in a pandemic [13,14]. Based on our experience, we believe
that it is possible to get such estimates during the peak of a first
wave if not sooner using population-based survey methods to
measure ILI prevalence in one or more geographic locations with
clear evidence that thousands of infections are occurring (e.g., a
substantial number of fatalities and clear increases in ILI). The
challenges are to be able to adjust for background ILI rates and to
time the survey(s) correctly to capture peak activity. In NYC, we
were able to initially adjust for background ILI using rates of ILI in
boroughs not heavily affected. However, in retrospect, we believe
it is possible to use other measures of influenza activity, such as ED
or sentinel provider visits to determine what percentage of ILI is
due to causes other than influenza. The one time when such
methods might be difficult to use is if a pandemic strain first
emerged at a time when ‘‘background’’ ILI rates were particularly
unstable from year to year, especially during the time periods
when seasonal influenza usually occurs. An additional possible
method to adjust for background ILI might have been to test a
random sample of persons with ILI, including those who did not
seek medical care, for nH1N1. However, that was logistically
impossible at the time as all testing resources were focused on
surveillance for severe illness and there was no serologic test
available, Further, the percentage of ILI that was nH1N1 was
likely constantly changing as the epidemic waxed and waned both
overall and in different parts of the NYC. The overlapping time
periods covered by the surveys made for an additional challenge to
combine the data. Our desire to obtain contextual information
early in the pandemic lead to rapid development and implemen-
tation of the first survey to measure ILI prevalence during the first
three weeks of the pandemic. Realizing we might miss the peak
without additional information, we initiated the second survey less
than a month later and used a standard 30 day period to measure
ILI prevalence. With 20-20 hindsight, a single well timed survey
might have sufficed for measuring CFR but would not have
provided the early data that indicated that nH1N1 had rapidly
spread citywide and had affected 5–10% of the population in
several boroughs. In the future, use of population-based surveys
may be a faster and more accurate alternative than multiplier
methods.
Limitations
The major limitations of this study include the low survey
response rate and the inability to measure nH1N1 prevalence
directly. The low survey response rate was in part a predictable
and necessary consequence of the rapidity with which the surveys
were conducted, a limitation that can be expected whenever rapid
polling methods are used. Additional survey-related limitations are
those associated with any telephone survey, specifically recall, self-
report and the potential for those with land line telephones to be
different than those in the rest of the population. There are also
limitations associated with conducting death surveillance and
hospitalization surveillance. If a clinician does not think that a
death could be influenza-related and/or fails to conduct testing or
report to either public health authorities or the medical examiner,
it will not be recognized and counted. Hospitalization surveillance
relied in part on initial screening testing with an insensitive rapid
antigen test for influenza A, and upon both clinician recognition of
influenza and reporting in response to frequent telephone
prompts. For ICU surveillance, however, only the clinical
recognition of influenza and reporting was a limitation: nH1N1
specific testing was offered to all with acute respiratory illness,
including ILI. These limitations all result in under measurement of
fatalities and hospitalizations. The strengths of this approach
include the rapid availability of the data, and the ability to capture
data on children as well as adults. Of note, as of June 2010, no
nH1N1 seroprevalence data on NYC residents following the
Spring 2009 outbreak has become available to assess the accuracy
of the prevalence estimates presented in this paper.
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